Anthony P. Zook's most recent trade in Neogenomics Inc. was a trade of 17,900 Common Stock done at an average price of $5.6 . Disclosure was reported to the exchange on Aug. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogenomics Inc. | Anthony P. Zook | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.58 per share. | 06 Aug 2025 | 17,900 | 38,066 (0%) | 0% | 5.6 | 99,954 | Common Stock |
| Neogenomics Inc. | Anthony P. Zook | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 12,254 | 0 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Anthony P. Zook | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2025 | 12,254 | 23,590 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Anthony P. Zook | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Jun 2025 | 3,424 | 20,166 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Anthony P. Zook | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.88 per share. | 06 May 2025 | 18,900 | 18,900 (0%) | 0% | 7.9 | 148,919 | Common Stock |
| Neogenomics Inc. | Anthony P. Zook | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 729,927 | 729,927 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Anthony P. Zook | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 421,496 | 421,496 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Anthony P. Zook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2024 | 11,336 | 0 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Anthony P. Zook | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2024 | 11,336 | 11,336 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Anthony P. Zook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 12,254 | 12,254 | - | - | Restricted Stock Unit | |
| Neogenomics Inc. | Anthony P. Zook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 8,672 | 8,672 | - | - | Stock Option (Right to Buy) |